Table 1.
Changes in MAP and PVP during PVO, intraportal injection of microspheres and re-PVO after microsphere injections in experiment 1 (mean±SE).
| Basal | PVO | Microsphere injection | Re-PVO | |
| MAP (kPa) | ||||
| Group 1 | 11.6±0.4 | 13.0±0.3a | 8.8±0.4a | 9.0±0.4c |
| Group 2 | 11.2±0.3 | 13.2±0.5a | 8.5±0.3a | 9.3±0.3c |
| Group 3 | 11.4±0.4 | 12.6±0.3a | 11.5±3.9 | 12.4±0.3 |
| PVP (kPa) | ||||
| Group 1 | 4.1±0.3 | 13.0±0.3b | 4.5±0.3a | 8.4±0.3c |
| Group 2 | 4.5±0.2 | 13.2±0.4b | 5.1±0.2a | 9.2±0.2c |
| Group 3 | 4.2±0.2 | 12.6±0.3b | 4.2±0.2 | 12.4±0.3 |
Group 1: 15 μm microspheres; group 2: 80 μm microspheres; group 3: saline control. MAP, mean arterial pressure; PVP, portal venous pressure; PVO, portal venous occlusion.
P<0.05;
P<0.01 vs Basal.
P<0.05 vs PVO.